Hye-Won Shin is a biomedical engineer with a chemical engineering background and clinical translational science experience. She earned her Master’s Degree in Chemical Engineering at the Korea Advanced Institute of Science and Technology (KAIST), and holds a Ph.D. in Chemical and Biochemical Engineering and Materials Science from the University of California, Irvine (UCI).
Hye-Won has extensive experience in developing minimally invasive medical technologies utilizing breath gas biomarkers to detect and follow malignancy, infection, and inflammation. She is an inventor on three issued and two pending patents. Hye-Won is a project scientist at UCI where she works closely with engineers, chemists, and respiratory physiologist to translate engineering technology into the medical marketplace.